nalidixic acid has been researched along with Prostatic Hyperplasia in 3 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madsen, PO | 2 |
| Rhodes, PR | 1 |
| Rached-Mohassel, MA | 1 |
| Hanjani, AA | 1 |
| Nik-Akhtar, B | 1 |
| Chariat, C | 1 |
| Tabibi, M | 1 |
| Genster, HG | 1 |
3 other studies available for nalidixic acid and Prostatic Hyperplasia
| Article | Year |
|---|---|
Oxolinic acid, a new chemotherapeutic agent in the treatment of urinary tract infection.
Topics: Aged; Anti-Infective Agents, Urinary; Chemical Phenomena; Chemistry; Chronic Disease; Drug Resistanc | 1971 |
[Cholestatic hepatitis induced by the prolonged administration of nalidixic acid (case report)].
Topics: Aged; Alkaline Phosphatase; Chemical and Drug Induced Liver Injury; Cholangitis; Cholestasis; Humans | 1974 |
Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Bacteriuria; Ceph | 1970 |